C-reactive protein, cardiovascular risk factors and the association with myocardial infarction in men

被引:37
作者
Doggen, CJM
Berckmans, RJ
Sturk, A
Cats, VM
Rosendaal, FR
机构
[1] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Clin Chem, NL-2300 RC Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Cardiol, NL-2300 RC Leiden, Netherlands
[4] Leiden Univ, Med Ctr, Ctr Hemostasis & Thrombosis Res, NL-2300 RC Leiden, Netherlands
关键词
C-reactive protein; inflammation marker; myocardial infarction; risk factors;
D O I
10.1046/j.1365-2796.2000.00754.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. This study had three objectives: first, to investigate the association of C-reactive protein levels and myocardial infarction amongst men; secondly, to study the associations of C-reactive protein levels with cardiovascular risk factors; and thirdly, to adjust the risk of myocardial infarction for such factors. Design and subjects. A case-control study including 560 patients with a first myocardial infarction who had survived at least 6 months, plus 646 control subjects. Results. Patients had significantly higher levels of C-reactive protein (mean 2.2 mg L-1) than control subjects (mean 1.7 mg L-1; P < 0.001). Persons in the highest quintile of C-reactive protein had an unadjusted 1.9-fold increased risk of myocardial infarction compared with persons in the lowest quintile (odds ratio 1.9, 95% CI: 1.3-2.7). C-reactive protein was, in addition to smoking, associated with several cardiovascular risk factors: age, obesity, diabetes, blood pressure, triglycerides and inversely associated to HDL cholesterol. Adjustment for these variables, especially for total cholesterol, HDL cholesterol and triglycerides, substantially decreased the risk of myocardial infarction for persons in the highest quintile of C-reactive protein, compared to those in the fewest quintile, to 1.3 (95% CI: 0.9-1.9). Conclusions. Our findings confirm previous reports that C-reactive protein predicts the risk of myocardial infarction. However, this association does not appear to be causal, since the increase in risk can to a large extent be explained by the presence of other cardiovascular risk factors.
引用
收藏
页码:406 / 414
页数:9
相关论文
共 30 条
  • [1] INFLAMMATION AND CORONARY-ARTERY DISEASE
    ALEXANDER, RW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (07) : 468 - 469
  • [2] [Anonymous], CASE CONTROL STUDIES
  • [3] ELEVATION OF C-REACTIVE PROTEIN IN ACTIVE CORONARY-ARTERY DISEASE
    BERK, BC
    WEINTRAUB, WS
    ALEXANDER, RW
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (03) : 168 - 172
  • [4] Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability
    Biasucci, LM
    Liuzzo, G
    Grillo, RL
    Caligiuri, G
    Rebuzzi, AG
    Buffon, A
    Summaria, F
    Ginnetti, F
    Fadda, G
    Maseri, A
    [J]. CIRCULATION, 1999, 99 (07) : 855 - 860
  • [5] C-REACTIVE PROTEIN INDUCES HUMAN PERIPHERAL-BLOOD MONOCYTES TO SYNTHESIZE TISSUE FACTOR
    CERMAK, J
    KEY, NS
    BACH, RR
    BALLA, J
    JACOB, HS
    VERCELLOTTI, GM
    [J]. BLOOD, 1993, 82 (02) : 513 - 520
  • [6] Risk factors for coronary heart disease and acute-phase proteins - A population-based study
    Danesh, J
    Muir, J
    Wong, YK
    Ward, M
    Gallimore, JR
    Pepys, MB
    [J]. EUROPEAN HEART JOURNAL, 1999, 20 (13) : 954 - 959
  • [7] Interaction of coagulation defects and cardiovascular risk factors - Increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A
    Doggen, CJM
    Cats, VM
    Bertina, RM
    Rosendaal, FR
    [J]. CIRCULATION, 1998, 97 (11) : 1037 - 1041
  • [8] Tissue-type plasminogen activator and C-reactive protein in acute coronary heart disease. A nested case-control study
    Gram, J
    Bladbjerg, EM
    Moller, L
    Sjol, A
    Jespersen, J
    [J]. JOURNAL OF INTERNAL MEDICINE, 2000, 247 (02) : 205 - 212
  • [9] Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5
  • [10] von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects - The Hoorn study
    Jager, A
    van Hinsbergh, VWM
    Kostense, PJ
    Emeis, JJ
    Yudkin, JS
    Nijpels, G
    Dekker, JM
    Heine, RJ
    Bouter, LM
    Stehouwer, CDA
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (12) : 3071 - 3078